Top Markets
Coin of the day
Mizuho Medy Co.,Ltd. Mizuho Medy Co.,Ltd.

Mizuho Medy Co.,Ltd.

4595
Rang in Aktien #18058
Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd.... Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd. specializes in the research, development, production, and distribution of in-vitro diagnostic solutions, complemented by scientific and technical information services. While its primary operations are in Japan, the company maintains an international presence through import and export activities, extending its reach to countries including the United States, Belgium, Finland, the Netherlands, Taiwan, and Thailand. Its extensive product lineup includes a wide array of immunoassay test kits designed for detecting pathogens such as influenza viruses, RS virus, human metapneumovirus, Streptococcus pneumoniae, Legionella, Mycoplasma pneumoniae, adenovirus, rotavirus, norovirus, and Group A streptococcus. Additionally, Mizuho Medy offers kits for pregnancy, ovulation, and fecal occult blood screening. The company also provides advanced tools like gene analysis instruments and specialized diagnostic kits for SARS-CoV-2 detection and Mycoplasma pneumoniae nucleic acid analysis.
Aktienkurs
$11.23
Marktkapitalisierung
$214.01M
Veränderung (1 Tag)
-0.06%
Veränderung (1 Jahr)
5.75%
Land
JP
Handel Mizuho Medy Co.,Ltd. (4595)

Kategorie

P/B-Verhältnis für Mizuho Medy Co.,Ltd. (4595)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Mizuho Medy Co.,Ltd. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Mizuho Medy Co.,Ltd. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber